Profile data is unavailable for this security.
About the company
Peptonic Medical AB is a Sweden-based company active in the field of biotechnology. The Company develops estrogen-free pharmaceuticals for treatment of vaginal atrophy. The Company's main drug candidate is Vagitocin, an oxytocin-based pharmaceutical preparation for the treatment of vaginal atrophy and other menopause-related symptoms. The patented treatment is based on local, vaginal application of oxytocin to rejuvenate the vaginal mucosa. Vagitocin is to enter phase III clinical trials in Europe and the United States.
- Revenue in SEK (TTM)15.69m
- Net income in SEK-48.98m
- Incorporated2009
- Employees3.00
- LocationPeptonic Medical ABGustavslundsvagen 143BROMMA 167 51SwedenSWE
- Phone+46 853020110
- Fax+46 470731550
- Websitehttps://www.peptonicmedical.se/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ATTANA AB | 4.10m | -12.78m | 20.64m | 6.00 | -- | 0.6084 | -- | 5.03 | -0.0154 | -0.0154 | 0.0047 | 0.0132 | 0.1425 | -0.7611 | 1.02 | 656,600.00 | -44.37 | -37.91 | -61.34 | -48.09 | 161.16 | 189.23 | -311.34 | -305.50 | 0.6079 | -3.79 | 0.1315 | -- | -18.77 | -8.69 | 7.33 | -- | 8.51 | -- |
| Lumito AB (publ) | 81.51k | -48.06m | 23.95m | 8.00 | -- | 0.1728 | -- | 293.81 | -20.16 | -20.16 | 0.0253 | 40.27 | 0.0008 | -0.4224 | 0.0791 | 6,792.50 | -47.58 | -24.12 | -62.09 | -26.46 | 546.44 | -- | -58,966.97 | -138,894.00 | 0.2668 | -22.92 | 0.1994 | -- | -- | -- | -61.08 | -- | -30.66 | -- |
| Aptahem AB | 0.00 | -7.43m | 31.57m | -- | -- | 0.2568 | -- | -- | -0.6711 | -0.6711 | 0.00 | 3.77 | 0.00 | -- | -- | -- | -11.21 | -30.70 | -11.57 | -34.24 | -- | -- | -- | -- | -- | -44.15 | 0.00 | -- | -- | -- | 22.90 | -- | 88.99 | -- |
| Guard Therapeutics Intrntnl AB (publ) | 0.00 | -118.48m | 33.28m | 5.00 | -- | 0.5981 | -- | -- | -7.65 | -7.65 | 0.00 | 2.76 | 0.00 | -- | -- | 0.00 | -161.81 | -71.09 | -197.78 | -79.80 | -- | -- | -- | -- | -- | -1,537.69 | 0.00 | -- | -- | -- | 15.23 | -- | -- | -- |
| Strategic Partners A/S | 0.00 | -4.71m | 35.39m | 1.00 | -- | 1.39 | -- | -- | -83.43 | -83.43 | 0.00 | 433.01 | 0.00 | -- | -- | 0.00 | -18.16 | -66.13 | -19.52 | -94.41 | -- | -- | -- | -- | -- | -69.91 | 0.00 | -- | -- | -- | 98.86 | -- | -- | -- |
| Peptonic Medical AB | 15.69m | -48.98m | 37.35m | 3.00 | -- | 0.5344 | -- | 2.38 | -0.0068 | -0.0068 | 0.002 | 0.0037 | 0.1994 | 0.6491 | 3.47 | 2,242,000.00 | -62.23 | -52.80 | -86.90 | -72.84 | 67.85 | 54.48 | -312.10 | -141.78 | 0.2747 | -26.44 | 0.2863 | -- | -27.55 | 43.57 | -40.95 | -- | 11.04 | -- |
| Modus Therapeutics Holding AB | 0.00 | -17.94m | 38.80m | 2.00 | -- | 2.67 | -- | -- | -0.1796 | -0.1796 | 0.00 | 0.1196 | 0.00 | -- | -- | 0.00 | -137.62 | -123.65 | -167.64 | -208.97 | -- | -- | -- | -- | -- | -63.99 | 0.00 | -- | -- | -- | 13.14 | -- | -- | -- |
| 2cureX AB | 25.00k | 3.06m | 45.69m | 0.00 | 8.80 | 72.98 | -- | 1,827.49 | 0.2068 | 0.2068 | 0.0012 | 0.0249 | 0.0041 | -- | 0.0148 | -- | 50.01 | -45.04 | 179.24 | -49.69 | -12,972.00 | -44,478.89 | 12,228.00 | -109,947.80 | -- | -- | 0.00 | -- | -- | -- | 88.14 | -- | -- | -- |
| Larkberget AB | 252.00k | -35.46m | 45.94m | 1.00 | -- | 0.831 | -- | 182.30 | -1.79 | -1.79 | 0.0127 | 2.79 | 0.0031 | -- | 0.2702 | 25,200.00 | -43.82 | -16.31 | -47.28 | -17.54 | -- | -- | -14,069.77 | -81.71 | -- | -- | 0.00 | -- | -94.13 | -- | -25.83 | -- | -- | -- |
| Acousort AB | 5.62m | -12.36m | 54.18m | 16.00 | -- | 2.90 | -- | 9.65 | -0.7188 | -0.7188 | 0.3101 | 0.8814 | 0.2799 | -0.0274 | 49.25 | 350,937.50 | -61.61 | -48.79 | -81.29 | -71.44 | 101.21 | 63.17 | -220.12 | -285.72 | 4.51 | -- | 0.00 | -- | -14.40 | 20.61 | 11.77 | -- | -- | -- |
Data as of Feb 11 2026. Currency figures normalised to Peptonic Medical AB's reporting currency: Swedish Krona SEK
